Sudeep Pharma is gearing up for its stock market entry. The IPO will commence on Friday, November 21. The company plans to issue 1.6 million new shares, along with an offer for sale of approximately 13.5 million shares. The sentiment in the grey market is currently optimistic. On Thursday morning, the Grey Market Premium (GMP) was reported at ₹130, according to market analysts. The upper price band for the IPO is set at ₹593 per share. With the GMP factored in, the stock is expected to debut at around ₹723, reflecting a nearly 22% increase over the issue price, indicating robust demand prior to the IPO launch.
